Tech Company Financing Transactions
Netris Pharma Funding Round
European Innovation Council Fund participated in a $26.7 million funding round for Netris Pharma. This venture round closed on 12/19/2023.
Transaction Overview
Company Name
Announced On
12/19/2023
Transaction Type
Venture Equity
Amount
$26,700,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to reach all endpoints of its clinical development plan and for corporate development purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Centre Léon Bérard 28 rue Laennec
Lyon , 69008
France
Lyon , 69008
France
Phone
Undisclosed
Website
Email Address
Overview
Operator of a biopharmaceutical company intended to drive superior clinical benefits for patients in the treatment of cancer. The company's therapies work by targeting the dependence receptors to effectively restore the dependence receptor apoptosis signaling pathway in the absence of the required stimulus, enabling physicians and doctors to effectively cure cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Mehlen
Chief Medical Officer
Frédéric Le Bras
Chief Scientific Officer
Agnès Bernet
Browse more venture capital transactions:
Prev: 12/19/2023: ScaleOps venture capital transaction
Next: 12/20/2023: Base Operations venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs